Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Tur-Kaspa

Showing results (111-120 of 146) with videos related to

Pageof 15
Sort By:
Transplantation Proceedings|September 7, 2001
Transfusion-transmitted virus in liver-transplanted childrenR Shapira, R Zemel, S Gerecht, et al.
The American Journal of Gastroenterology|March 10, 2000
Syncytial giant-cell hepatitis due to autoimmune hepatitis type II (LKM1+) presenting as subfulminant hepatitisZ Ben-Ari, E Broida, Y Monselise, et al.
The American Journal of Gastroenterology|January 1, 1990
Familial Budd-Chiari syndrome due to membranous obstruction of the right hepatic vein treated with transluminal angioplastyR D Feigin, M Glickson, A Varstending, et al.
Israel Journal of Medical Sciences|April 1, 1994
Clinical, serological and molecular characteristics of 471 hepatitis B virus carriersS Bar-Shany, T Shohat, R Tur-Kaspa, et al.
Journal of Medical Virology|August 1, 1991
Prevalence of HBsAg carriers in native and immigrant pregnant female populations in Israel and passive/active vaccination against HBV of newborns at riskV Bogomolski-Yahalom, E Granot, N Linder, et al.
Virology|December 1, 1988
The glucocorticoid receptor recognizes a specific nucleotide sequence in hepatitis B virus DNA causing increased activity of the HBV enhancerR Tur-Kaspa, Y Shaul, D D Moore, et al.
Transplantation Proceedings|June 18, 1999
Differences in immunoactivation between heart and liver transplanted patientsE Erez, E Sharoni, A Erman, et al.
Transplantation Proceedings|September 7, 2001
Beta-2 microglobulin and serum creatinine for differentiating between immunoactivation and renal failure after liver transplantationE Erez, Z Ben-Ari, E Sharoni, et al.
Transplantation Proceedings|November 20, 1997
Utilization of liver allografts from donors older than 60 in Israel: benefits and risksE Mor, D Shmueli, N Bar-Nathan, et al.
Journal of General Internal Medicine|March 13, 2019
Teaching the Interplay Between Social Determinants of Health (SDH) and Health Outcomes: the ETGAR Student-Delivered ServiceS Spitzer-Shohat, D Sagi, M Schuster, et al.
Pageof 15

Showing results (111-120 of 146) with videos related to

Sort By:
Pageof 15
Transplantation Proceedings|September 7, 2001
Transfusion-transmitted virus in liver-transplanted childrenR Shapira, R Zemel, S Gerecht, et al.
The American Journal of Gastroenterology|March 10, 2000
Syncytial giant-cell hepatitis due to autoimmune hepatitis type II (LKM1+) presenting as subfulminant hepatitisZ Ben-Ari, E Broida, Y Monselise, et al.
The American Journal of Gastroenterology|January 1, 1990
Familial Budd-Chiari syndrome due to membranous obstruction of the right hepatic vein treated with transluminal angioplastyR D Feigin, M Glickson, A Varstending, et al.
Israel Journal of Medical Sciences|April 1, 1994
Clinical, serological and molecular characteristics of 471 hepatitis B virus carriersS Bar-Shany, T Shohat, R Tur-Kaspa, et al.
Journal of Medical Virology|August 1, 1991
Prevalence of HBsAg carriers in native and immigrant pregnant female populations in Israel and passive/active vaccination against HBV of newborns at riskV Bogomolski-Yahalom, E Granot, N Linder, et al.
Virology|December 1, 1988
The glucocorticoid receptor recognizes a specific nucleotide sequence in hepatitis B virus DNA causing increased activity of the HBV enhancerR Tur-Kaspa, Y Shaul, D D Moore, et al.
Transplantation Proceedings|June 18, 1999
Differences in immunoactivation between heart and liver transplanted patientsE Erez, E Sharoni, A Erman, et al.
Transplantation Proceedings|September 7, 2001
Beta-2 microglobulin and serum creatinine for differentiating between immunoactivation and renal failure after liver transplantationE Erez, Z Ben-Ari, E Sharoni, et al.
Transplantation Proceedings|November 20, 1997
Utilization of liver allografts from donors older than 60 in Israel: benefits and risksE Mor, D Shmueli, N Bar-Nathan, et al.
Journal of General Internal Medicine|March 13, 2019
Teaching the Interplay Between Social Determinants of Health (SDH) and Health Outcomes: the ETGAR Student-Delivered ServiceS Spitzer-Shohat, D Sagi, M Schuster, et al.
Pageof 15